OOIR: Observatory of International Research

Papers

(The TQCC of American Journal of Respiratory and Critical Care Medicine is 10. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-05-01 to 2024-05-01.)

Article	Citations
COVID-19 Does Not Lead to a “Typical” Acute Respiratory Distress Syndrome	1015
Idiopathic Pulmonary Fibrosis (an Update) and Progressive Pulmonary Fibrosis in Adults: An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline	853
Clinical Features of 85 Fatal Cases of COVID-19 from Wuhan. A Retrospective Observational Study	629
COVID-19 with Different Severities: A Multicenter Study of Clinical Features	595
Diagnosis of Hypersensitivity Pneumonitis in Adults: An Official ATS/JRS/ALAT Clinical Practice Guideline	511
Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2	475
Characterization of the Inflammatory Response to Severe COVID-19 Illness	447
Why COVID-19 Silent Hypoxemia Is Baffling to Physicians	419
Global Initiative for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease. The 2020 GOLD Science Committee Report on COVID-19 and Chronic Obstructive Pulmonary Disease	417
Clinical Course and Outcomes of 344 Intensive Care Patients with COVID-19	373
COVID-19–related Genes in Sputum Cells in Asthma. Relationship to Demographic Features and Corticosteroids	325
Respiratory Pathophysiology of Mechanically Ventilated Patients with COVID-19: A Cohort Study	319
Endothelial Responses in Sepsis	297
A Single-Cell Atlas of the Human Healthy Airways	290
COVID-19–associated Pulmonary Aspergillosis	269
Coughs and Sneezes: Their Role in Transmission of Respiratory Viral Infections, Including SARS-CoV-2	260
Tobacco Smoking Increases the Lung Gene Expression of ACE2, the Receptor of SARS-CoV-2	250
Case Fatality Rates for Patients with COVID-19 Requiring Invasive Mechanical Ventilation. A Meta-analysis	233
Tissue-Specific Immunopathology in Fatal COVID-19	232
Pulmonary Angiopathy in Severe COVID-19: Physiologic, Imaging, and Hematologic Observations	225
Lung Recruitability in COVID-19–associated Acute Respiratory Distress Syndrome: A Single-Center Observational Study	217
Senescence of Alveolar Type 2 Cells Drives Progressive Pulmonary Fibrosis	205
Basing Respiratory Management of COVID-19 on Physiological Principles	205
Pharmacologic Management of Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline	200
Hospital Preparedness for COVID-19: A Practical Guide from a Critical Care Perspective	200

Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes	196
Expression of the SARS-CoV-2 ACE2 Receptor in the Human Airway Epithelium	189
Symptoms of Anxiety, Depression, and Peritraumatic Dissociation in Critical Care Clinicians Managing Patients with COVID-19. A Cross-Sectional Study	186
High-Flow Nasal Cannula in Critically III Patients with Severe COVID-19	176
Lung- and Diaphragm-Protective Ventilation	168
Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study	163
SARS-CoV-2 Viral Load in Clinical Samples from Critically Ill Patients	161
Clinical Effectiveness of Elexacaftor/Tezacaftor/Ivacaftor in People with Cystic Fibrosis: A Clinical Trial	155
Early Inspiratory Effort Assessment by Esophageal Manometry Predicts Noninvasive Ventilation Outcome in De Novo Respiratory Failure. A Pilot Study	155
Ventilatory Variables and Mechanical Power in Patients with Acute Respiratory Distress Syndrome	154
Mechanical Ventilation in COVID-19: Interpreting the Current Epidemiology	153
A Phase 3 Open-Label Study of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 through 11 Years of Age with Cystic Fibrosis and at Least One F508del Allele	152
Uncontrolled Innate and Impaired Adaptive Immune Responses in Patients with COVID-19 Acute Respiratory Distress Syndrome	151
Reduction in All-Cause Mortality with Fluticasone Furoate/Umeclidinium/Vilanterol in Patients with Chronic Obstructive Pulmonary Disease	146
Rapid Improvement after Starting Elexacaftor–Tezacaftor–Ivacaftor in Patients with Cystic Fibrosis and Advanced Pulmonary Disease	142
Cystic Fibrosis: Emergence of Highly Effective Targeted Therapeutics and Potential Clinical Implications	141
The Structural and Social Determinants of the Racial/Ethnic Disparities in the U.S. COVID-19 Pandemic. What’s Our Role?	137
Air Pollution, Genetic Factors, and the Risk of Lung Cancer: A Prospective Study in the UK Biobank	137
Initiating Pharmacologic Treatment in Tobacco-Dependent Adults. An Official American Thoracic Society Clinical Practice Guideline	131
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary	131
Reduced All-Cause Mortality in the ETHOS Trial of Budesonide/Glycopyrrolate/Formoterol for Chronic Obstructive Pulmonary Disease. A Randomized, Double-Blind, Multicenter, Parallel-Group Study	130
Home Oxygen Therapy for Adults with Chronic Lung Disease. An Official American Thoracic Society Clinical Practice Guideline	128
Latent Class Analysis Reveals COVID-19–related Acute Respiratory Distress Syndrome Subgroups with Differential Responses to Corticosteroids	127
An Updated Definition and Severity Classification of Chronic Obstructive Pulmonary Disease Exacerbations: The Rome Proposal	126
Time Kinetics of Viral Clearance and Resolution of Symptoms in Novel Coronavirus Infection	126
Occurrence of Invasive Pulmonary Fungal Infections in Patients with Severe COVID-19 Admitted to the ICU	125
Addressing Disparities in Lung Cancer Screening Eligibility and Healthcare Access. An Official American Thoracic Society Statement	124
From GOLD 0 to Pre-COPD	119
Effect of Lowering Vt on Mortality in Acute Respiratory Distress Syndrome Varies with Respiratory System Elastance	116
Definition and Nomenclature of Chronic Obstructive Pulmonary Disease: Time for Its Revision	115
Safety and Efficacy of Elexacaftor/Tezacaftor/Ivacaftor for 24 Weeks or Longer in People with Cystic Fibrosis and One or More F508del Alleles: Interim Results of an Open-Label Phase 3 Clinical	114
Respiratory Mechanics of COVID-19– versus Non–COVID-19–associated Acute Respiratory Distress Syndrome	113
Ineffectual Type 2–to–Type 1 Alveolar Epithelial Cell Differentiation in Idiopathic Pulmonary Fibrosis: Persistence of the KRT8^hi Transitional State	112
Sleep Apnea–Specific Hypoxic Burden, Symptom Subtypes, and Risk of Cardiovascular Events and All-Cause Mortality	111
Secretory Cells Dominate Airway CFTR Expression and Function in Human Airway Superficial Epithelia	111
Aerosol Generation from the Respiratory Tract with Various Modes of Oxygen Delivery	110
Inflammatory Endotype–associated Airway Microbiome in Chronic Obstructive Pulmonary Disease Clinical Stability and Exacerbations: A Multicohort Longitudinal Analysis	109
Monocyte Count as a Prognostic Biomarker in Patients with Idiopathic Pulmonary Fibrosis	105
Machine Learning Classifier Models Can Identify Acute Respiratory Distress Syndrome Phenotypes Using Readily Available Clinical Data	104
Increased Odds of Death for Patients with Interstitial Lung Disease and COVID-19: A Case–Control Study	103
Assessing the Accuracy of a Deep Learning Method to Risk Stratify Indeterminate Pulmonary Nodules	103
Single-Cell Reconstruction of Human Basal Cell Diversity in Normal and Idiopathic Pulmonary Fibrosis Lungs	102
Evidence for Exacerbation-Prone Asthma and Predictive Biomarkers of Exacerbation Frequency	101
Bacterial Superinfection Pneumonia in Patients Mechanically Ventilated for COVID-19 Pneumonia	100
Renin and Survival in Patients Given Angiotensin II for Catecholamine-Resistant Vasodilatory Shock. A Clinical Trial	98
Trends in Intensive Care for Patients with COVID-19 in England, Wales, and Northern Ireland	96
Mitigating Inequities and Saving Lives with ICU Triage during the COVID-19 Pandemic	95
Association between Initial Treatment Strategy and Long-Term Survival in Pulmonary Arterial Hypertension	95
The Early Change in Pa_CO₂after Extracorporeal Membrane Oxygenation Initiation Is Associated with Neurological Complications	95
New Physical, Mental, and Cognitive Problems 1 Year after ICU Admission: A Prospective Multicenter Study	94

Injury to the Endothelial Glycocalyx in Critically Ill Patients with COVID-19	94
The Epidemiological Importance of Subclinical Tuberculosis. A Critical Reappraisal	92
The Sleep Apnea–Specific Pulse-Rate Response Predicts Cardiovascular Morbidity and Mortality	91
Safety and Efficacy of B-Cell Depletion with Rituximab for the Treatment of Systemic Sclerosis–associated Pulmonary Arterial Hypertension: A Multicenter, Double-Blind, Randomized, Placebo-controlled T	91
High Prevalence of Pulmonary Sequelae at 3 Months after Hospital Discharge in Mechanically Ventilated Survivors of COVID-19	90
Characterization of Disease Phenotype in Very Preterm Infants with Severe Bronchopulmonary Dysplasia	90
Airway Occlusion Pressure As an Estimate of Respiratory Drive and Inspiratory Effort during Assisted Ventilation	90
Necroptosis Signaling Promotes Inflammation, Airway Remodeling, and Emphysema in Chronic Obstructive Pulmonary Disease	89
Sleep Apnea and COVID-19 Mortality and Hospitalization	88
ACE2 Elevation in Severe COVID-19	87
Long-Term Noninvasive Ventilation in Chronic Stable Hypercapnic Chronic Obstructive Pulmonary Disease. An Official American Thoracic Society Clinical Practice Guideline	84
Norepinephrine Dysregulates the Immune Response and Compromises Host Defense during Sepsis	84
Respiratory Syncytial Virus Infection Promotes Necroptosis and HMGB1 Release by Airway Epithelial Cells	84
Home Monitoring in Patients with Idiopathic Pulmonary Fibrosis. A Randomized Controlled Trial	83
Lung Ultrasound to Monitor Extremely Preterm Infants and Predict Bronchopulmonary Dysplasia. A Multicenter Longitudinal Cohort Study	82
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on CFTR Function in Patients with Cystic Fibrosis and One or Two F508del Alleles	81
Natural History of Cognitive Impairment in Critical Illness Survivors. A Systematic Review	81
Compliance Phenotypes in Early Acute Respiratory Distress Syndrome before the COVID-19 Pandemic	81
Pitolisant for Daytime Sleepiness in Patients with Obstructive Sleep Apnea Who Refuse Continuous Positive Airway Pressure Treatment. A Randomized Trial	80
Changes to Visitation Policies and Communication Practices in Michigan ICUs during the COVID-19 Pandemic	79
Using Bayesian Methods to Augment the Interpretation of Critical Care Trials. An Overview of Theory and Example Reanalysis of the Alveolar Recruitment for Acute Respiratory Distress Syndrome Trial	78
Multinight Prevalence, Variability, and Diagnostic Misclassification of Obstructive Sleep Apnea	76
Air Pollution as a Risk Factor for Incident Chronic Obstructive Pulmonary Disease and Asthma. A 15-Year Population-based Cohort Study	76
Asthma and Obstructive Sleep Apnea Overlap: What Has the Evidence Taught Us?	74
Inhaled Steroids, Circulating Eosinophils, Chronic Airway Infection, and Pneumonia Risk in Chronic Obstructive Pulmonary Disease. A Network Analysis	74
Treatment Trials in Young Patients with Chronic Obstructive Pulmonary Disease and Pre–Chronic Obstructive Pulmonary Disease Patients: Time to Move Forward	74
Severe Adult Asthmas: Integrating Clinical Features, Biology, and Therapeutics to Improve Outcomes	74
Mucus Plugs and Emphysema in the Pathophysiology of Airflow Obstruction and Hypoxemia in Smokers	73
Use of Fractional Exhaled Nitric Oxide to Guide the Treatment of Asthma: An Official American Thoracic Society Clinical Practice Guideline	73
Ventilator Sharing during an Acute Shortage Caused by the COVID-19 Pandemic	73
Characterization of Eosinophilic Bronchiectasis: A European Multicohort Study	72
Latent Tuberculosis: Two Centuries of Confusion	71
Ivacaftor in Infants Aged 4 to <12 Months with Cystic Fibrosis and a Gating Mutation. Results of a Two-Part Phase 3 Clinical Trial	70
Procalcitonin to Reduce Long-Term Infection-associated Adverse Events in Sepsis. A Randomized Trial	70
Asthma in Adult Patients with COVID-19. Prevalence and Risk of Severe Disease	70
High Respiratory Drive and Excessive Respiratory Efforts Predict Relapse of Respiratory Failure in Critically Ill Patients with COVID-19	69
Ventilatory Ratio in Hypercapnic Mechanically Ventilated Patients with COVID-19–associated Acute Respiratory Distress Syndrome	69
Bronchoscopy in Patients with COVID-19 with Invasive Mechanical Ventilation: A Single-Center Experience	69
Pulmonary Arterial Hypertension: Diagnosis, Treatment, and Novel Advances	69
Development and Progression of Radiologic Abnormalities in Individuals at Risk for Familial Interstitial Lung Disease	68
Respiratory and Cardiovascular Outcomes in Survivors of Extremely Preterm Birth at 19 Years	67
Equitably Allocating Resources during Crises: Racial Differences in Mortality Prediction Models	67
Chronic Hypersensitivity Pneumonitis, an Interstitial Lung Disease with Distinct Molecular Signatures	66
Reconsidering the Utility of Race-Specific Lung Function Prediction Equations	66
A Case of COVID-19 and Pneumocystis jirovecii Coinfection	65
Race and Ethnicity in Pulmonary Function Test Interpretation: An Official American Thoracic Society Statement	65
Pulmonary Vascular Dilatation Detected by Automated Transcranial Doppler in COVID-19 Pneumonia	64
Effect of Positive End-Expiratory Pressure and Proning on Ventilation and Perfusion in COVID-19 Acute Respiratory Distress Syndrome	64
Decreased Fatty Acid Oxidation and Altered Lactate Production during Exercise in Patients with Post-acute COVID-19 Syndrome	64
Home Nitric Oxide Therapy for COVID-19	63
Single-Cell Transcriptomic Analysis Identifies a Unique Pulmonary Lymphangioleiomyomatosis Cell	63
Early Bacterial Identification among Intubated Patients with COVID-19 or Influenza Pneumonia: A European Multicenter Comparative Clinical Trial	63
Airspace Macrophages and Monocytes Exist in Transcriptionally Distinct Subsets in Healthy Adults	63
Interstitial Lung Disease in Relatives of Patients with Pulmonary Fibrosis	63
Machine Learning for Early Lung Cancer Identification Using Routine Clinical and Laboratory Data	63
Long-Term Safety and Efficacy of Tocilizumab in Early Systemic Sclerosis–Interstitial Lung Disease: Open-Label Extension of a Phase 3 Randomized Controlled Trial	63
Blood Eosinophils and Chronic Obstructive Pulmonary Disease: A Global Initiative for Chronic Obstructive Lung Disease Science Committee 2022 Review	63
Expert Consensus on the Tapering of Oral Corticosteroids for the Treatment of Asthma. A Delphi Study	63
Omalizumab for Aspirin Hypersensitivity and Leukotriene Overproduction in Aspirin-exacerbated Respiratory Disease. A Randomized Controlled Trial	62
YTHDF1 Regulates Pulmonary Hypertension through Translational Control of MAGED1	62
A New Global Definition of Acute Respiratory Distress Syndrome	61
Detection of Invasive Pulmonary Aspergillosis in COVID-19 with Nondirected BAL	61
Endotypic Mechanisms of Successful Hypoglossal Nerve Stimulation for Obstructive Sleep Apnea	61
Chemokine Receptor 2–targeted Molecular Imaging in Pulmonary Fibrosis. A Clinical Trial	61
Blood Eosinophil Counts in Clinical Trials for Chronic Obstructive Pulmonary Disease	61
Episodic Aspiration with Oral Commensals Induces a MyD88-dependent, Pulmonary T-Helper Cell Type 17 Response that Mitigates Susceptibility to Streptococcus pneumoniae	60
Prone Positioning of Nonintubated Patients with COVID-19	58
Effects of Weight Loss on Obstructive Sleep Apnea Severity. Ten-Year Results of the Sleep AHEAD Study	58
Bedaquiline-Resistant Tuberculosis: Dark Clouds on the Horizon	58
Metagenomics Reveals a Core Macrolide Resistome Related to Microbiota in Chronic Respiratory Disease	58
Syndrome of Combined Pulmonary Fibrosis and Emphysema: An Official ATS/ERS/JRS/ALAT Research Statement	58
Sustained Coinfections withStaphylococcus aureusandPseudomonas aeruginosain Cystic Fibrosis	58
Asthma Exacerbations in Patients with Type 2 Diabetes and Asthma on Glucagon-like Peptide-1 Receptor Agonists	57
Opioid Use Increases the Risk of Delirium in Critically Ill Adults Independently of Pain	57
Electrical Impedance Tomography for Positive End-Expiratory Pressure Titration in COVID-19–related Acute Respiratory Distress Syndrome	57
Alveolar, Endothelial, and Organ Injury Marker Dynamics in Severe COVID-19	56
What Is Asthma?	56
Utility of a Molecular Classifier as a Complement to High-Resolution Computed Tomography to Identify Usual Interstitial Pneumonia	56
Bronchial Thermoplasty Induced Airway Smooth Muscle Reduction and Clinical Response in Severe Asthma. The TASMA Randomized Trial	55
Hospital-Free Days: A Pragmatic and Patient-centered Outcome for Trials among Critically and Seriously Ill Patients	54

Race/Ethnicity, Spirometry Reference Equations, and Prediction of Incident Clinical Events: The Multi-Ethnic Study of Atherosclerosis (MESA) Lung Study	54
Lung Function Trajectories Leading to Chronic Obstructive Pulmonary Disease as Predictors of Exacerbations and Mortality	54
Extracorporeal Membrane Oxygenation for COVID-19–associated Severe Acute Respiratory Distress Syndrome in Chile: A Nationwide Incidence and Cohort Study	53
A Race-neutral Approach to the Interpretation of Lung Function Measurements	53
Extracorporeal Membrane Oxygenation for Critically Ill Patients with COVID-19–related Acute Respiratory Distress Syndrome: Worth the Effort?	53
Diagnosis and Management of COVID-19 Disease	53
Effects of Elexacaftor/Tezacaftor/Ivacaftor Therapy on Lung Clearance Index and Magnetic Resonance Imaging in Patients with Cystic Fibrosis and One or Two F508del Alleles	53
Single-Cell Transcriptional Archetypes of Airway Inflammation in Cystic Fibrosis	53
Outpatient Inhaled Nitric Oxide in a Patient with Vasoreactive Idiopathic Pulmonary Arterial Hypertension and COVID-19 Infection	53
Vitamin D Metabolism Is Dysregulated in Asthma and Chronic Obstructive Pulmonary Disease	52
Efficacy and Safety of Elexacaftor/Tezacaftor/Ivacaftor in Children 6 Through 11 Years of Age with Cystic Fibrosis Heterozygous for F508del and a Minimal Function Mutation: A Phase 3b, Randomiz	52
Single-Session Bronchial Thermoplasty Guided by ¹²⁹Xe Magnetic Resonance Imaging. A Pilot Randomized Controlled Clinical Trial	52
Thrombomodulin Alfa for Acute Exacerbation of Idiopathic Pulmonary Fibrosis. A Randomized, Double-Blind Placebo-controlled Trial	52
Respiratory Tract Dysbiosis Is Associated with Worse Outcomes in Mechanically Ventilated Patients	52
Interventional Bronchoscopy	50
Peri-intubation Cardiovascular Collapse in Patients Who Are Critically Ill: Insights from the INTUBE Study	50
Hyperoxia Injury in the Developing Lung Is Mediated by Mesenchymal Expression of Wnt5A	50
Effect of Continuous Positive Airway Pressure on Arrhythmia in Atrial Fibrillation and Sleep Apnea: A Randomized Controlled Trial	50
The Effect of Sleep Apnea on Cardiovascular Events in Different Acute Coronary Syndrome Phenotypes	50
Risk Factors for Mortality after COVID-19 in Patients with Preexisting Interstitial Lung Disease	50
Race, Lung Function, and Long-Term Mortality in the National Health and Nutrition Examination Survey III	49
The POOR Get POORer: A Hypothesis for the Pathogenesis of Ventilator-induced Lung Injury	49
A Network of Sputum MicroRNAs Is Associated with Neutrophilic Airway Inflammation in Asthma	49
Metformin: Experimental and Clinical Evidence for a Potential Role in Emphysema Treatment	49
A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment	49
Prone Position and Lung Ventilation and Perfusion Matching in Acute Respiratory Failure due to COVID-19	49
Prevalence and Population-Attributable Risk for Chronic Airflow Obstruction in a Large Multinational Study	49
Effect of Esophageal Pressure–guided Positive End-Expiratory Pressure on Survival from Acute Respiratory Distress Syndrome: A Risk-based and Mechanistic Reanalysis of the EPVent-2 Trial	48
Urinary Leukotriene E₄and Prostaglandin D₂Metabolites Increase in Adult and Childhood Severe Asthma Characterized by Type 2 Inflammation. A Clinical Observational Study	48
Dynamics of the Upper Respiratory Tract Microbiota and Its Association with Mortality in COVID-19	48
Inhibition of Caspase-1 with Tetracycline Ameliorates Acute Lung Injury	48
High In-Hospital Mortality Rate in Patients with COVID-19 Receiving Extracorporeal Membrane Oxygenation in Germany: A Critical Analysis	47
Sex Differences in Right Ventricular–Pulmonary Arterial Coupling in Pulmonary Arterial Hypertension	47
Recurrent Severe Preschool Wheeze: From Prespecified Diagnostic Labels to Underlying Endotypes	47
Muscle Protein Synthesis after Protein Administration in Critical Illness	47
Increased Angiotensin-Converting Enzyme 2 and Loss of Alveolar Type II Cells in COVID-19–related Acute Respiratory Distress Syndrome	46
Positive Airway Pressure Adherence, Mortality, and Cardiovascular Events in Patients with Sleep Apnea	46
Comparison of 6-Month Outcomes of Survivors of COVID-19 versus Non–COVID-19 Critical Illness	46
COVID-19 and Public Interest in Face Mask Use	46
Biological Subphenotypes of Acute Respiratory Distress Syndrome Show Prognostic Enrichment in Mechanically Ventilated Patients without Acute Respiratory Distress Syndrome	45
The Respiratory Microbiome in Chronic Hypersensitivity Pneumonitis Is Distinct from That of Idiopathic Pulmonary Fibrosis	45
Trajectory of Preserved Ratio Impaired Spirometry: Natural History and Long-Term Prognosis	45
Loss of DP1 Aggravates Vascular Remodeling in Pulmonary Arterial Hypertension via mTORC1 Signaling	45
Comparative Effectiveness of Protective Ventilation Strategies for Moderate and Severe Acute Respiratory Distress Syndrome. A Network Meta-Analysis	45
Importance of Early COPD in Young Adults for Development of Clinical COPD. Findings from the Copenhagen General Population Study	45
Mucus Plugs Persist in Asthma, and Changes in Mucus Plugs Associate with Changes in Airflow over Time	45
Localization of Macrophages in the Human Lung via Design-based Stereology	44
Whole-Blood RNA Profiles Associated with Pulmonary Arterial Hypertension and Clinical Outcome	44
Complement Inhibition with the C5 Blocker LFG316 in Severe COVID-19	44
Radiology–Pathology Correlation Demonstrating Organizing Pneumonia in a Patient Who Recovered from COVID-19	44
Long Noncoding RNA TYKRIL Plays a Role in Pulmonary Hypertension via the p53-mediated Regulation of PDGFRβ	44
COVID-19– versus non–COVID-19–related Acute Respiratory Distress Syndrome: Differences and Similarities	44
Positive End-Expiratory Pressure, Pleural Pressure, and Regional Compliance during Pronation. An Experimental Study	44
BACES Score for Predicting Mortality in Nontuberculous Mycobacterial Pulmonary Disease	43
Serial Measurement of Cell-Cycle Arrest Biomarkers [TIMP-2] · [IGFBP7] and Risk for Progression to Death, Dialysis, or Severe Acute Kidney Injury in Patients with Septic Shock	43
Long-Term Outcomes in ICU Patients with Delirium: A Population-based Cohort Study	43
Associations of Sleep-disordered Breathing and Insomnia with Incident Hypertension and Diabetes. The Hispanic Community Health Study/Study of Latinos	43
Residual Lung Abnormalities after COVID-19 Hospitalization: Interim Analysis of the UKILD Post–COVID-19 Study	43
Pharmacotherapy and Lung Function Decline in Patients with Chronic Obstructive Pulmonary Disease. A Systematic Review	42
Risk-stratified Management to Remove Low-Risk Penicillin Allergy Labels in the ICU	42
Cigarette Smoking and COVID-19: A Complex Interaction	42
Effects of Inhaled Corticosteroid/Long-Acting β₂-Agonist Combination on the Airway Microbiome of Patients with Chronic Obstructive Pulmonary Disease: A Randomized Controlled Clinical Trial	42
Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma	42
Respirable Crystalline Silica Exposure, Smoking, and Lung Cancer Subtype Risks. A Pooled Analysis of Case–Control Studies	42
Patient-centered Outcomes Research in Interstitial Lung Disease: An Official American Thoracic Society Research Statement	42
E-Cigarette or Vaping Product Use–associated Lung Injury: Developing a Research Agenda. An NIH Workshop Report	42
Airway Sensory Nerve Density Is Increased in Chronic Cough	42
Circulating MicroRNAs and Treatment Response in Childhood Asthma	41
Association of Positive End-Expiratory Pressure and Lung Recruitment Selection Strategies with Mortality in Acute Respiratory Distress Syndrome: A Systematic Review and Network Meta-analysis	41
Inspiratory Effort and Lung Mechanics in Spontaneously Breathing Patients with Acute Respiratory Failure due to COVID-19: A Matched Control Study	41
An All-Oral 6-Month Regimen for Multidrug-Resistant Tuberculosis: A Multicenter, Randomized Controlled Clinical Trial (the NExT Study)	41
Detecting Deteriorating Patients in the Hospital: Development and Validation of a Novel Scoring System	41
rhIGF-1/BP3 Preserves Lung Growth and Prevents Pulmonary Hypertension in Experimental Bronchopulmonary Dysplasia	41
Bacterial Mucosal Immunotherapy with MV130 Prevents Recurrent Wheezing in Children: A Randomized, Double-Blind, Placebo-controlled Clinical Trial	41
Impulse Dispersion of Aerosols during Singing and Speaking: A Potential COVID-19 Transmission Pathway	40
A Research Agenda for Precision Medicine in Sepsis and Acute Respiratory Distress Syndrome: An Official American Thoracic Society Research Statement	40
Risk Reduction and Hemodynamics with Initial Combination Therapy in Pulmonary Arterial Hypertension	40
Asthma Phenotypes and COVID-19 Risk: A Population-based Observational Study	40
Prenatal, Early-Life, and Childhood Exposure to Air Pollution and Lung Function: The ALSPAC Cohort	40
Invasive Tracheobronchial Aspergillosis in Critically Ill Patients with Severe Influenza. A Clinical Trial	40
Mixed Sputum Granulocyte Longitudinal Impact on Lung Function in the Severe Asthma Research Program	40
Identifying Clinical Research Priorities in Adult Pulmonary and Critical Care. NHLBI Working Group Report	40
Passive Prophylactic Administration with a Single Dose of Anti–Fel d 1 Monoclonal Antibodies REGN1908–1909 in Cat Allergen–induced Allergic Rhinitis: A Randomized, Double-Blind, Placebo-controlled Cli	40
Magnetic Resonance Imaging Detects Progression of Lung Disease and Impact of Newborn Screening in Preschool Children with Cystic Fibrosis	40
Chronic Effects of High Fine Particulate Matter Exposure on Lung Cancer in China	40
Imaging the Respiratory Transition at Birth: Unraveling the Complexities of the First Breaths of Life	39
Randomized Clinical Trial of Air Cleaners to Improve Indoor Air Quality and Chronic Obstructive Pulmonary Disease Health: Results of the CLEAN AIR Study	39
Live-attenuated Vaccines Prevent Respiratory Syncytial Virus–associated Illness in Young Children	39
High-Flow Nasal Oxygen for Severe Hypoxemia: Oxygenation Response and Outcome in Patients with COVID-19	39
Home High-Flow Nasal Cannula Oxygen Therapy for Stable Hypercapnic COPD: A Randomized Clinical Trial	38
Early Bactericidal Activity of Different Isoniazid Doses for Drug-Resistant Tuberculosis (INHindsight): A Randomized, Open-Label Clinical Trial	38
Impact of Positive Airway Pressure Therapy Adherence on Outcomes in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease	38
Macrophage–NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension	38
Validation of Proposed Criteria for Progressive Pulmonary Fibrosis	38
Hospital-Level Variation in Death for Critically Ill Patients with COVID-19	38